VERACYTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
VERACYTE, INC. (VCYT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-26
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2016-09-30 was 20.30K shares, a 90.85% decline year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2016-06-30 was 160.40K shares, a 31.80% increase year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2016-03-31 was 1.26M shares, a 16.35% increase year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-12-31 was 94.75K shares, a 60.55% decline year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 1.52M shares, a 2.19% increase from fiscal 2014.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 1.49M shares, a 114.16% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2016-09-30 | 20.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 180.70K shares derived: sum of 2 quarters · filed 2016-11-03 | 1.44M shares 10-Q · filed 2016-11-03 | 1.54M shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 160.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | 1.42M shares 10-Q · filed 2016-08-03 | 1.51M shares derived: sum of 3 quarters · filed 2016-08-03 | 1.74M shares derived: sum of 4 quarters · filed 2016-08-03 |
| 2016-03-31 | 1.26M shares 10-Q · filed 2016-05-05 | 1.35M shares derived: sum of 2 quarters · filed 2016-05-05 | 1.58M shares derived: sum of 3 quarters · filed 2016-05-05 | 1.70M shares derived: sum of 4 quarters · filed 2016-05-05 |
| 2015-12-31 | 94.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 316.73K shares derived: sum of 2 quarters · filed 2016-03-14 | 438.43K shares derived: sum of 3 quarters · filed 2016-03-14 | 1.52M shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 221.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 343.68K shares derived: sum of 2 quarters · filed 2015-11-05 | 1.43M shares 10-Q · filed 2015-11-05 | 1.67M shares derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | 121.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 1.20M shares 10-Q · filed 2015-08-13 | 1.44M shares derived: sum of 3 quarters · filed 2015-08-13 | 1.66M shares derived: sum of 4 quarters · filed 2015-08-13 |
| 2015-03-31 | 1.08M shares 10-Q · filed 2015-05-15 | 1.32M shares derived: sum of 2 quarters · filed 2015-05-15 | 1.54M shares derived: sum of 3 quarters · filed 2015-05-15 | 1.72M shares derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-12-31 | 240.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | 454.65K shares derived: sum of 2 quarters · filed 2015-03-25 | 638.40K shares derived: sum of 3 quarters · filed 2015-03-25 | 1.49M shares 10-K · filed 2015-03-25 |
| 2014-09-30 | 214.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 398.25K shares derived: sum of 2 quarters · filed 2014-11-13 | 1.25M shares 10-Q · filed 2014-11-13 | -634.71M shares derived: sum of 4 quarters · filed 2015-03-25 |
| 2014-06-30 | 183.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | 1.03M shares 10-Q · filed 2014-08-14 | -634.93M shares derived: sum of 3 quarters · filed 2015-03-25 | |
| 2014-03-31 | 850.09K shares 10-Q · filed 2014-05-09 | -635.11M shares derived: sum of 2 quarters · filed 2015-03-25 | ||
| 2013-12-31 | -635.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | 695.03K shares 10-K · filed 2015-03-25 | ||
| 2013-09-30 | 636.65M shares 10-Q · filed 2013-11-25 | |||
| 2012-12-31 | 931.94K shares 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |